WHO ICTRP trial
Acromegaly is a syndrome that results when the pituitary gland produces excess…
EUCTR2010-021008-77-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-021008-77-SE |
|---|---|
| Public title | Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone. It most commonly affects adults in middle age. Acromegaly is often also associated with gigantism. |
| Scientific title | A MULTI - CENTER OPEN LABEL PHASE II (B) STUDY TO ASSESS EFFECTS OF SOM230 ON CARDIOVASCULAR PARAMETERS IN ACROMEGALIC PATIENTS - PASIREOTIDE/01/2010 (CSOM230CSE01T) |
| Primary sponsor | Göteborgs Universitet, Göteborg Sweden |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands;Italy;Sweden |
| Conditions | Adult patients 18 to 80 years of age with diagnosed acromegaly eligible for treatment with a somatostatin analogue and not on previous pharmacological treatment for acromegaly.;Therapeutic area: Diseases [C] - Hormonal diseases [C19] |
| Interventions | Product Name: PASIREOTIDE Product Code: SOM230 Pharmaceutical Form: Powder and solvent for suspension for injection INN or Proposed INN: Pasireotide Current Sponsor code: SOM230 Concentration unit: IU/mg international unit(s)/milligram… |
| Registration date | May 23, 2011 |
| Target size | 20 |
| Secondary IDs | PASIREOTIDE/01/2010 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: